Patent classifications
C07D251/26
USE OF 2,4-DIHALO-6-SUBSTITUTED-1,3,5-TRIAZINES AND DERIVATIVE THEREOF AS CONDENSATION, CROSS-LINKING, TANNING, GRAFTING AND CURING AGENTS
Use of 2,4-dihalo-6-substituted-1,3,5-triazines as condensing, cross-linking, tanning, grafting, curing agents for the production of amides, esters, thioesters, and stabilized collagen and leather, CMC (carboxymethyl cellulose), synthetic and natural polymers. The process enables to obtain non-toxic and totally free of heavy metals products characterized by Tg values between 80 C. and 100 C.
USE OF 2,4-DIHALO-6-SUBSTITUTED-1,3,5-TRIAZINES AND DERIVATIVE THEREOF AS CONDENSATION, CROSS-LINKING, TANNING, GRAFTING AND CURING AGENTS
Use of 2,4-dihalo-6-substituted-1,3,5-triazines as condensing, cross-linking, tanning, grafting, curing agents for the production of amides, esters, thioesters, and stabilized collagen and leather, CMC (carboxymethyl cellulose), synthetic and natural polymers. The process enables to obtain non-toxic and totally free of heavy metals products characterized by Tg values between 80 C. and 100 C.
METHOD FOR PRODUCING ISOCYANURIC ACID DERIVATIVE HAVING ONE HYDROCARBON GROUP
A method for producing an isocyanuric acid derivative having one hydrocarbon group. The method having a hydrocarbon group including a first step of obtaining a compound of the following formula (1) from the compound of formula (0), a second step of obtaining a compound of the following formula (2) from the compound of formula (1), a third step of obtaining a compound of the following formula (3) from the compound of formula (2), and a fourth step of obtaining a compound of the following formula (4) from the compound of formula (3):
##STR00001##
(wherein X.sub.1s are each a chlorine atom, a fluorine atom, or a bromine atom, Bn is a benzyl group in which at least one hydrogen atom in a benzene ring is optionally substituted with methyl group, and R is a C.sub.1-10 hydrocarbon group), wherein all the steps are carried out at a temperature of not exceeding 100 C.
METHOD FOR PRODUCING ISOCYANURIC ACID DERIVATIVE HAVING TWO HYDROCARBON GROUPS
A method for producing an isocyanuric acid derivative having two hydrocarbon groups including: a first step of obtaining a compound of Formula (1); a second step of obtaining a compound of Formula (2) from the compound of Formula (1); a third step of obtaining a compound of Formula (3) from the compound of Formula (2); and a fourth step of obtaining a compound of Formula (4) from the compound of Formula (3), wherein Bn is a benzyl group, and two Rs are each a C.sub.1-10 hydrocarbon group, wherein all the steps are carried out at a temperature not exceeding 100 C.
1,3,5-TRIAZINE DERIVATIVE AND METHOD OF USING SAME
Disclosed are compounds having formulae I and II or pharmaceutically acceptable salts or hydrates thereof, a preparation method thereof and pharmaceutical compositions thereof. The compounds having formulae I and II possesses an isocitrate dehydrogenase 2 (IDH2) inhibitory activity and are capable of treating IDH2 mutation-induced cancers.
##STR00001##
Process for Preparing a Triazine-Based Precursor, the Precursor Prepared Thereby, a Method for Producing a Micro-Particulate Complex Using the Precursor, and the Micro-Particulate Complex Produced Thereby
A process for preparing a triazine-based precursor for producing a micro-particulate complex containing a far infrared-emissive silica particle comprises steps of: a) subjecting 2-4-6-trichloro-1,3,5-triazine and a first nucleophilic compound to a displacement reaction in the presence of a first solvent at a first temperature range to form an intermediate; and b) subjecting the intermediate and a second nucleophilic compound to a further displacement reaction in the presence of a second solvent at a second temperature range higher than the first temperature range.
Process for Preparing a Triazine-Based Precursor, the Precursor Prepared Thereby, a Method for Producing a Micro-Particulate Complex Using the Precursor, and the Micro-Particulate Complex Produced Thereby
A process for preparing a triazine-based precursor for producing a micro-particulate complex containing a far infrared-emissive silica particle comprises steps of: a) subjecting 2-4-6-trichloro-1,3,5-triazine and a first nucleophilic compound to a displacement reaction in the presence of a first solvent at a first temperature range to form an intermediate; and b) subjecting the intermediate and a second nucleophilic compound to a further displacement reaction in the presence of a second solvent at a second temperature range higher than the first temperature range.
METHOD FOR THE INDUSTRIAL PRODUCTION OF 2-HALO-4,6-DIALKOXY-1,3,5-TRIAZINES AND THEIR USE IN THE PRESENCE OF AMINES
A method for stabilization of collagen matrices and of condensation of natural and synthetic polymers that uses 2-halo-4, 6-dialkoxy-1, 3, 5-triazines in the presence of one or more amines as activating agents for reactions of crosslinking, condensation, grafting, and curing of collagen matrices, cellulose, modified celluloses, polysaccharides, acid unsaturated polymers, and chiral and non-chiral amines, etc. Forming an integral part of the present invention is also the method for production on an industrial scale of 2-halo-4, 6-dialkoxy-1, 3, 5-triazines.
METHOD FOR THE INDUSTRIAL PRODUCTION OF 2-HALO-4,6-DIALKOXY-1,3,5-TRIAZINES AND THEIR USE IN THE PRESENCE OF AMINES
A method for stabilization of collagen matrices and of condensation of natural and synthetic polymers that uses 2-halo-4, 6-dialkoxy-1, 3, 5-triazines in the presence of one or more amines as activating agents for reactions of crosslinking, condensation, grafting, and curing of collagen matrices, cellulose, modified celluloses, polysaccharides, acid unsaturated polymers, and chiral and non-chiral amines, etc. Forming an integral part of the present invention is also the method for production on an industrial scale of 2-halo-4, 6-dialkoxy-1, 3, 5-triazines.
SULFONAMIDES, METHOD FOR PREPARATION THEREOF, AND USE THEREOF
The present disclosure discloses sulfonamides, methods for preparation thereof and uses thereof, belonging to the technical field of medicinal chemistry. The structure of the sulfonamides of the present disclosure is shown in Formula I. The present disclosure also provides use of the compound of Formula I or a salt, solvate, isomer, metabolite, nitrogen-oxide, or prodrug thereof in the manufacture of a medicament for the treatment or prevention of P2X3 and/or P2X2/3 receptor-associated diseases. The sulfonamides of the present disclosure have a potent cough suppressing effect and a significantly prolonged action. Their inhibitory activity against P2X3 is superior to that of Comparative compound 1 and the positive control Gefapixant.
##STR00001##